Bluerock Acquisition Corp. (NASDAQ:BLRK – Get Free Report) saw a significant decrease in short interest in October. As of October 15th, there was short interest totaling 1,135 shares, a decrease of 40.8% from the September 30th total of 1,918 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 60,349 shares, the short-interest ratio is currently 0.0 days.
Bluerock Acquisition Stock Performance
Bluerock Acquisition stock traded down $0.01 during midday trading on Friday, reaching $10.12. The company’s stock had a trading volume of 18,113 shares, compared to its average volume of 48,692. The business has a 50-day moving average price of $10.11 and a 200-day moving average price of $10.01. Bluerock Acquisition has a 52 week low of $9.87 and a 52 week high of $10.68.
Analysts Set New Price Targets
Separately, Weiss Ratings raised shares of Bluerock Acquisition from a “sell (e-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Bluerock Acquisition currently has an average rating of “Sell”.
Get Our Latest Research Report on Bluerock Acquisition
Bluerock Acquisition Company Profile
Bluerock Acquisition (NASDAQ:BLRK) is a special purpose acquisition company, or SPAC, formed to identify and complete a business combination with an operating company. Its potential transaction may take the form of a merger, acquisition, stock exchange, asset acquisition, reorganization or similar combination.
Unlike an operating company, Bluerock Acquisition does not appear to sell products or provide services directly to customers. Its activities primarily involve evaluating potential target businesses, conducting due diligence and seeking shareholder approval for a proposed transaction.
Information about a specific acquisition target, operating geographies and the company’s leadership is limited.
Featured Stories
- Five stocks we like better than Bluerock Acquisition
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
- LyondellBasell’s Dividend Looks Safer, But a New Risk Could Change That
Receive News & Ratings for Bluerock Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluerock Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
